Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000206328 | SCV000262188 | likely benign | Ataxia-telangiectasia syndrome | 2023-07-07 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000439365 | SCV000526976 | likely benign | not specified | 2016-04-18 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Counsyl | RCV000206328 | SCV000793241 | uncertain significance | Ataxia-telangiectasia syndrome | 2017-08-08 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV000777916 | SCV000913956 | likely benign | Hereditary cancer-predisposing syndrome | 2018-05-11 | criteria provided, single submitter | clinical testing | |
Myriad Genetics, |
RCV004589901 | SCV005085816 | likely benign | Familial cancer of breast | 2024-05-23 | criteria provided, single submitter | clinical testing | This variant is considered likely benign. This variant is intronic and is not expected to impact mRNA splicing. |
Prevention |
RCV004547501 | SCV004784356 | likely benign | ATM-related disorder | 2024-01-23 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |